Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Non Operating Investment Income: 2011-2018

Historic Non Operating Investment Income for EyePoint Pharmaceuticals (EYPT) over the last 5 years, with Sep 2018 value amounting to -$18.9 million.

  • EyePoint Pharmaceuticals' Non Operating Investment Income was N/A to -$18.9 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$44.0 million, marking a year-over-year change of. This contributed to the annual value of -$26.3 million for FY2018, which is N/A change from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Non Operating Investment Income stood at -$18.9 million for Q3 2018, which was up 17.09% from -$22.8 million recorded in Q2 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Non Operating Investment Income ranged from a high of $9,000 in Q1 2016 and a low of -$22.8 million during Q2 2018.
  • For the 2-year period, EyePoint Pharmaceuticals' Non Operating Investment Income averaged around -$7.3 million, with its median value being -$1.2 million (2016).
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Non Operating Investment Income plummeted by 200.00% in 2015 and then spiked by 800.00% in 2016.
  • EyePoint Pharmaceuticals' Non Operating Investment Income (Quarterly) stood at -$2,000 in 2014, then crashed by 200.00% to -$6,000 in 2015, then crashed by 50.00% to $1,000 in 2016, then reached -$18.9 million in 2018.
  • Its Non Operating Investment Income stands at -$18.9 million for Q3 2018, versus -$22.8 million for Q2 2018 and -$2.3 million for Q1 2018.